CA3298663A1 - Composés pharmaceutiques - Google Patents

Composés pharmaceutiques

Info

Publication number
CA3298663A1
CA3298663A1 CA3298663A CA3298663A CA3298663A1 CA 3298663 A1 CA3298663 A1 CA 3298663A1 CA 3298663 A CA3298663 A CA 3298663A CA 3298663 A CA3298663 A CA 3298663A CA 3298663 A1 CA3298663 A1 CA 3298663A1
Authority
CA
Canada
Prior art keywords
pharmaceutical compounds
pharmaceutical
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3298663A
Other languages
English (en)
Inventor
Matthew Duncan HELM
Adam Piotr TREDER
James Samuel Shane Rountree
Mary MCFARLAND
Steven David Shepherd
Natalia Wanda SALEWSKA
Frank Burkamp
Original Assignee
Almac Discovery Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Almac Discovery Ltd filed Critical Almac Discovery Ltd
Publication of CA3298663A1 publication Critical patent/CA3298663A1/fr
Pending legal-status Critical Current

Links

CA3298663A 2023-07-21 2024-07-19 Composés pharmaceutiques Pending CA3298663A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2311227.9 2023-07-21

Publications (1)

Publication Number Publication Date
CA3298663A1 true CA3298663A1 (fr) 2025-01-30

Family

ID=

Similar Documents

Publication Publication Date Title
GB202200753D0 (en) Pharmaceutical compounds
AU2020356348B2 (en) Pharmaceutical compounds
CA3261419A1 (fr) Composition pharmaceutique comprenant de la centanafadine
GB202213819D0 (en) Pharmaceutical compound
GB202201283D0 (en) Pharmaceutical compounds
CA3298663A1 (fr) Composés pharmaceutiques
HK40112311A (en) Pharmaceutical compound
HK40095641A (en) Pharmaceutical compounds
HK40102537A (zh) 药物化合物
AU2023901609A0 (en) Pharmaceutical composition
CA3286170A1 (fr) Dosage
IL326026A (en) Pharmaceutical materials
GB202312534D0 (en) Pharmaceutical compounds
GB202311018D0 (en) Pharmaceutical compounds
CA3305167A1 (fr) Composés ciblant la survivine
CA3301857A1 (fr) Composés contenant du cyclobutyle
CA3295507A1 (fr) Composés
CA3295511A1 (en) Compounds
CA3283976A1 (fr) Composés
AU2023903954A0 (en) Compounds
CA3275025A1 (fr) Composés
AU2023902053A0 (en) Compounds
AU2023902054A0 (en) Compounds
AU2023900353A0 (en) Compounds
AU2022904012A0 (en) Compounds